lower limb symptoms independent of CEAP clinical grade. Eur J
Vasc Endovasc Surg 2012;44:341-4.
6. Carradice D, Mazari FA, Samuel N, Allgar V, Hatﬁeld J, Chetter IC.
Modelling the effect of venous disease on quality of life. Br J Surg
2011;98:1089-98.
7. Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M,
Parsons N. Burden of venous leg ulcers in the United States. J Med
Econ 2014;17:347-56.
8. Davies AH. The seriousness of chronic venous disease: a review of
real-world evidence. Adv Ther 2019;36(Suppl 1):5-12.
9. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL,
Gloviczki ML, et al. The care of patients with varicose veins and
associated chronic venous diseases: clinical practice guidelines of
the Society for Vascular Surgery and the American Venous Forum.
J Vasc Surg 2011;53(5 Suppl):2s-48s.
10. Mallick R, Raju A, Campbell C, Carlton R, Wright D, Boswell K, et al.
Treatment patterns and outcomes in patients with varicose veins.
Am Health Drug Beneﬁts 2016;9:455-65.
11. Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, Elamin MB,
Duggirala MK, Erwin PJ, et al. A systematic review and meta-analysis
of the treatments of varicose veins. J Vasc Surg 2011;53:49S-65S.
12. Paravastu SCV, Horne M, Dodd PDF. Endovenous ablation therapy
(laser or radiofrequency) or foam sclerotherapy versus conventional
surgical repair for short saphenous varicose veins. Cochrane
Database Syst Rev 2016;11. CD01